Merit Medical Q1 2024 revenue $323.5M (+8.7% YoY); GAAP EPS $0.48 (+35.5%)

MERIT MEDICAL SYSTEMS INC

2024-Q1 EPS reported $0.48 revenue$323,508,000

Revenue $323.5M, up 8.7% YoY; constant currency revenue up 9.3%; organic constant currency up 7.0%.
GAAP operating margin 11.1% vs 8.9% in Q1 2023; non-GAAP operating margin 17.3% vs 16.1%.
GAAP EPS $0.48, up 35.5% from $0.36; non-GAAP EPS $0.77, up 18.7% from $0.64.
Non-GAAP measures include constant currency and organic growth; reconciliations in press release.
No specific guidance update provided; Q1 results discussed on April 30 conference call.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MERIT MEDICAL SYSTEMS INC reported first quarter ended March 31, 2024 results: revenue $323.5 million, EPS $0.48.

Period: first quarter ended March 31, 2024
Revenue: $323.5 million
EPS: $0.48
Result: reported results

Exact text from the filing

mike.piccinino@westwicke.com FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS RESULTS FOR FIRST QUARTER ENDED MARCH 31, 2024 ● Q1 2024 reported revenue of $323.5 million, up 8.7% compared to Q1 2023 ● Q1 2024 constant currency revenue* up 9.3% compared to Q1 2023 ● Q1 2024 constant currency revenue, organic* up 7.0% compared to Q1 2023 ● Q1 2024

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-24-000035

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.